Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Revvity (RVTY) Financials

Revvity logo
$95.40 +0.61 (+0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$95.44 +0.04 (+0.04%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Revvity

Annual Income Statements for Revvity

This table shows Revvity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/3/2016 1/1/2017 12/31/2017 12/30/2018 12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Net Income / (Loss) Attributable to Common Shareholders
212 234 293 238 228 728 943 569 693 270 241
Consolidated Net Income / (Loss)
212 234 293 238 228 728 943 569 693 270 241
Net Income / (Loss) Continuing Operations
189 216 157 237 228 631 889 513 180 283 240
Total Pre-Tax Income
209 244 297 258 237 800 1,204 652 183 316 268
Total Operating Income
251 295 296 324 362 867 1,258 743 301 347 357
Total Gross Profit
964 1,014 1,074 1,341 1,396 1,730 2,434 1,990 1,540 1,538 1,564
Total Revenue
2,105 2,116 2,257 2,778 2,884 2,663 3,828 3,312 2,751 2,755 2,856
Operating Revenue
2,105 2,116 2,257 2,778 2,884 2,663 3,828 3,312 2,751 2,755 2,856
Total Cost of Revenue
1,141 1,101 1,183 1,437 1,488 933 1,394 1,322 1,211 1,217 1,292
Operating Cost of Revenue
1,141 1,101 1,183 1,437 1,488 933 1,394 1,322 1,211 1,217 1,292
Total Operating Expenses
713 720 778 1,017 1,034 871 1,176 1,247 1,239 1,191 1,208
Selling, General & Admin Expense
587 590 626 812 815 716 975 1,026 1,023 994 992
Research & Development Expense
113 124 139 194 189 146 200 222 217 197 216
Total Other Income / (Expense), net
-42 -51 1.10 -66 -125 -67 -55 -91 -118 -31 -88
Interest Expense
42 51 -1.10 66 125 67 55 91 118 31 88
Income Tax Expense
20 28 140 20 9.39 170 314 139 3.47 33 28
Net Income / (Loss) Discontinued Operations
24 19 - - -0.20 97 - 57 514 -13 1.32
Basic Earnings per Share
$1.89 $2.14 $2.67 $2.15 $2.06 $6.52 $8.12 $4.51 $5.56 $2.21 $2.07
Weighted Average Basic Shares Outstanding
112.51M 109.48M 109.86M 110.56M 111.30M 224.12M 252.37M 126.41M 123.53M 120.19M 111.80M
Diluted Earnings per Share
$1.87 $2.12 $2.64 $2.13 $2.04 $6.49 $8.08 $4.50 $5.55 $2.20 $2.07
Weighted Average Diluted Shares Outstanding
112.51M 109.48M 109.86M 110.56M 111.30M 224.12M 252.37M 126.41M 123.53M 120.19M 111.80M
Weighted Average Basic & Diluted Shares Outstanding
112.51M 109.48M 109.86M 110.56M 111.30M 224.12M 252.37M 126.41M 123.53M 120.19M 111.80M
Cash Dividends to Common per Share
$0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28

Quarterly Income Statements for Revvity

This table shows Revvity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 4/5/2026
Net Income / (Loss) Attributable to Common Shareholders
9.50 79 26 55 94 95 42 54 47 98 41
Consolidated Net Income / (Loss)
9.50 79 26 55 94 95 42 54 47 98 41
Net Income / (Loss) Continuing Operations
32 64 29 73 93 88 42 55 47 96 41
Total Pre-Tax Income
51 31 35 87 100 95 52 69 56 92 50
Total Operating Income
69 77 44 86 98 119 72 91 82 112 76
Total Gross Profit
-298 1,054 355 386 385 412 376 393 375 422 388
Total Revenue
0.00 1,367 650 692 684 729 665 720 699 772 711
Operating Revenue
- - 650 692 684 729 665 720 699 772 711
Total Cost of Revenue
298 312 295 306 299 317 289 328 324 350 323
Operating Cost of Revenue
298 312 295 306 299 317 289 328 324 350 323
Total Operating Expenses
-367 977 311 300 287 294 303 302 293 310 312
Selling, General & Admin Expense
250 257 261 252 238 244 250 249 242 252 254
Research & Development Expense
53 50 50 48 49 49 54 53 51 58 58
Total Other Income / (Expense), net
-19 -46 -9.57 0.94 2.21 -24 -20 -22 -26 -20 -26
Interest Expense
19 46 9.57 -0.94 -2.21 24 20 22 26 20 26
Income Tax Expense
18 -32 5.85 14 6.97 6.18 11 13 8.46 -4.21 9.10
Net Income / (Loss) Discontinued Operations
-23 15 -2.68 -17 0.98 6.26 0.57 -1.27 -0.57 2.59 -0.18
Basic Earnings per Share
$0.08 $0.69 $0.21 $0.45 $0.77 $0.78 $0.35 $0.46 $0.40 $0.86 $0.36
Weighted Average Basic Shares Outstanding
123.99M 123.53M 123.43M 123.35M 122.81M 120.19M 120.14M 117.51M 115.41M 111.80M 111.85M
Diluted Earnings per Share
$0.08 $0.69 $0.21 $0.45 $0.77 $0.77 $0.35 $0.46 $0.40 $0.86 $0.36
Weighted Average Diluted Shares Outstanding
124.20M 123.53M 123.54M 123.48M 123.03M 120.19M 120.23M 117.54M 115.46M 111.80M 111.88M
Weighted Average Basic & Diluted Shares Outstanding
123.41M 123.53M 123.39M 123.34M 121.70M 120.19M 117.87M 116.07M 113.38M 111.80M 111.56M
Cash Dividends to Common per Share
$0.07 - $0.00 $0.00 $0.00 - $0.00 $0.00 $0.00 - $0.00

Annual Cash Flow Statements for Revvity

This table details how cash moves in and out of Revvity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/3/2016 1/1/2017 12/31/2017 12/30/2018 12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Net Change in Cash & Equivalents
63 138 -196 -28 26 211 -51 -115 444 250 -243
Net Cash From Operating Activities
287 351 288 311 363 892 1,411 680 91 628 583
Net Cash From Continuing Operating Activities
264 324 292 311 520 705 1,330 673 279 665 589
Net Income / (Loss) Continuing Operations
189 216 157 237 228 631 889 513 180 283 240
Consolidated Net Income / (Loss)
212 234 293 238 228 728 943 569 693 270 241
Net Income / (Loss) Discontinued Operations
24 19 136 0.45 0.20 97 - 57 514 -13 1.32
Depreciation Expense
105 100 105 181 214 202 311 427 432 428 405
Amortization Expense
8.77 2.53 8.78 23 25 5.22 40 53 7.35 6.07 4.55
Non-Cash Adjustments To Reconcile Net Income
-4.32 -27 11 24 61 19 1.97 50 52 -33 36
Changes in Operating Assets and Liabilities, net
-44 35 11 -152 -165 -151 -258 -370 -391 -20 -97
Net Cash From Discontinued Operating Activities
23 27 -3.70 -0.20 0.00 187 81 7.31 -188 -37 -6.02
Net Cash From Investing Activities
-101 -84 -1,267 -160 -488 -504 -4,113 -133 1,314 776 -17
Net Cash From Continuing Investing Activities
-99 -83 -1,539 -160 -488 -491 -4,090 -117 -761 619 -74
Purchase of Property, Plant & Equipment
-28 -32 -39 -93 -76 -64 -86 -86 -81 -87 -74
Acquisitions
-72 -72 -1,527 -98 -405 -411 -3,982 -7.52 -2.09 0.00 0.00
Purchase of Investments
0.00 0.00 -11 -7.02 -6.39 -20 -23 -47 -1,228 -6.59 -0.39
Divestitures
0.00 21 1.10 38 0.55 4.28 1.57 15 0.15 2.50 0.30
Sale and/or Maturity of Investments
0.00 0.00 37 0.00 0.00 0.00 0.00 0.00 550 710 0.00
Other Investing Activities, net
0.82 0.04 0.05 0.07 0.00 0.28 0.00 8.89 0.00 0.00 0.00
Net Cash From Discontinued Investing Activities
-1.41 -1.30 273 0.00 0.00 -14 -23 -16 2,075 157 56
Net Cash From Financing Activities
-107 -115 782 -179 150 -203 2,942 -662 -947 -1,128 -858
Net Cash From Continuing Financing Activities
-107 -115 783 -179 150 -203 2,942 -662 -947 -1,128 -858
Repayment of Debt
-486 -911 -239 -1,295 -2,248 -902 -1,943 -799 -518 -723 -3.00
Repurchase of Common Equity
-76 -152 -3.83 -57 -6.31 -6.94 -73 -81 -389 -370 -821
Payment of Dividends
-32 -31 -31 -31 -31 -31 -32 -35 -35 -34 -33
Issuance of Debt
451 967 1,061 1,226 2,447 715 4,986 240 0.00 0.00 0.00
Issuance of Common Equity
15 14 18 25 20 38 25 14 4.34 7.70 2.93
Other Financing Activities, net
21 -2.06 -23 -47 -31 -15 -21 -0.77 -10 -8.83 -3.84
Effect of Exchange Rate Changes
-16 -13 - 0.00 0.00 26 - - -14 -26 49
Cash Interest Paid
32 31 36 56 83 42 54 98 94 91 86
Cash Income Taxes Paid
49 44 78 60 77 162 365 323 360 155 0.00

Quarterly Cash Flow Statements for Revvity

This table details how cash moves in and out of Revvity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 4/5/2026
Net Change in Cash & Equivalents
-195 -210 85 250 -19 -66 -26 -146 -60 -12 -52
Net Cash From Operating Activities
-33 197 148 159 148 174 128 134 139 182 115
Net Cash From Continuing Operating Activities
31 221 150 182 157 175 134 134 139 182 126
Net Income / (Loss) Continuing Operations
32 64 29 73 93 88 42 55 47 96 41
Consolidated Net Income / (Loss)
9.50 79 26 55 94 95 42 54 47 98 41
Net Income / (Loss) Discontinued Operations
-23 15 -2.68 -17 0.98 6.26 0.57 -1.27 -0.57 2.59 -0.18
Depreciation Expense
108 106 108 107 108 105 97 103 102 103 105
Amortization Expense
1.98 1.55 1.74 1.77 1.54 1.02 1.10 1.22 1.24 0.99 1.14
Non-Cash Adjustments To Reconcile Net Income
34 88 31 12 -3.10 -73 7.67 23 24 -19 19
Changes in Operating Assets and Liabilities, net
-146 -38 -19 -12 -42 53 -14 -48 -36 1.15 -40
Net Cash From Discontinued Operating Activities
-64 -24 -2.58 -24 -9.13 -1.24 -5.94 - -0.08 - -11
Net Cash From Investing Activities
435 -415 -18 121 690 -17 -6.38 -9.49 19 -20 -78
Net Cash From Continuing Investing Activities
425 -415 -18 -26 690 -27 -16 -19 -19 -20 -78
Purchase of Property, Plant & Equipment
-22 -24 -18 -22 -22 -24 -16 -19 -19 -20 -20
Acquisitions
-1.40 - 0.00 - - - 0.00 - - - -67
Purchase of Investments
5.00 -397 -0.34 -4.34 4.34 - 0.00 - -0.03 -0.36 -1.06
Sale of Property, Plant & Equipment
- - - - - - 0.00 - - - 9.00
Divestitures
0.15 - 0.00 - - - 0.23 - - 0.08 0.16
Sale and/or Maturity of Investments
450 - 0.00 - 710 - 0.00 - - - 0.00
Other Investing Activities, net
- - 0.00 0.34 - - - - - - 0.68
Net Cash From Discontinued Investing Activities
9.47 - 0.00 148 - 9.38 9.38 9.38 38 - 0.00
Net Cash From Financing Activities
-586 -20 -35 -26 -874 -193 -164 -302 -215 -176 -89
Net Cash From Continuing Financing Activities
- -947 -35 - - -1,128 0.00 - - -858 -89
Repayment of Debt
-467 -6.73 -11 -0.39 -711 -0.82 -2.45 -0.13 -0.06 -0.36 0.00
Repurchase of Common Equity
-111 -4.87 -11 -20 -154 -185 -154 -294 -205 -168 -86
Payment of Dividends
-8.69 -8.64 -8.64 -8.64 -8.63 -8.54 -8.43 -8.28 -8.13 -7.96 -7.84
Issuance of Debt
- - 0.00 - - - 0.00 - - - 0.00
Other Financing Activities, net
0.51 -3.72 -4.81 2.09 0.06 -6.17 0.82 -0.16 -1.86 -2.63 5.44
Net Cash From Discontinued Financing Activities
- - - - - - 0.00 - - - 0.00

Annual Balance Sheets for Revvity

This table presents Revvity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/3/2016 1/1/2017 12/31/2017 12/30/2018 12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Total Assets
4,166 4,277 6,091 5,976 6,539 7,960 15,001 14,130 13,565 12,392 12,168
Total Current Assets
1,033 1,190 1,200 1,235 1,374 2,239 2,441 3,289 3,001 2,350 2,240
Cash & Equivalents
238 359 202 163 192 402 603 454 913 1,163 920
Short-Term Investments
- - - - - - - 0.00 690 0.00 0.00
Accounts Receivable
415 426 552 633 725 1,155 708 613 633 632 745
Inventories, net
259 247 352 338 357 515 426 405 428 368 379
Other Current Assets
64 99 94 101 100 167 148 122 337 186 196
Other Current Nonoperating Assets
56 59 0.00 - 0.00 0.00 555 1,694 0.00 0.00 0.00
Plant, Property, & Equipment, net
138 145 298 319 318 368 486 483 510 482 479
Plant, Property & Equipment, gross
- - - - - - - - - - 0.00
Accumulated Depreciation
- - - - - - - - - - 0.00
Total Noncurrent Assets
2,996 2,941 4,593 4,422 4,846 5,353 12,074 10,358 10,054 9,561 9,449
Long-Term Investments
- - - - - - - - - - 0.00
Goodwill
2,237 2,248 3,002 2,953 3,111 3,447 6,627 6,482 6,534 6,464 6,613
Intangible Assets
486 420 1,347 1,200 1,283 1,366 3,822 3,377 3,022 2,641 2,347
Other Noncurrent Operating Assets
198 205 244 270 451 540 481 499 498 456 489
Other Noncurrent Nonoperating Assets
75 68 0.00 - 0.00 0.00 1,144 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
4,166 4,277 6,091 5,976 6,539 7,960 15,001 14,130 13,565 12,392 12,168
Total Liabilities
2,056 2,123 3,588 3,391 3,725 4,225 7,859 6,747 5,692 4,726 4,918
Total Current Liabilities
561 603 951 772 763 1,652 1,214 1,544 1,450 653 1,331
Short-Term Debt
1.12 1.17 217 15 9.97 381 4.24 471 722 0.24 589
Accounts Payable
141 168 222 221 236 327 325 273 204 167 185
Accrued Expenses
382 400 501 529 503 944 679 528 524 485 557
Other Current Liabilities
17 7.48 8.76 4.83 12 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Nonoperating Liabilities
20 27 2.10 2.17 2.11 0.00 206 273 0.00 0.00 0.00
Total Noncurrent Liabilities
1,477 1,520 2,637 2,619 2,962 2,573 6,646 5,202 4,241 4,073 3,587
Long-Term Debt
1,012 1,045 1,789 1,877 2,064 1,610 4,980 3,923 3,178 3,150 2,631
Other Noncurrent Operating Liabilities
465 460 849 742 898 963 1,574 1,279 1,064 922 956
Other Noncurrent Nonoperating Liabilities
- 15 0.00 - 0.00 0.00 92 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,110 2,154 2,503 2,585 2,814 3,735 7,141 7,383 7,873 7,667 7,250
Total Preferred & Common Equity
2,110 2,154 2,503 2,585 2,814 3,735 7,141 7,383 7,873 7,667 7,250
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,110 2,154 2,503 2,585 2,814 3,735 7,141 7,383 7,873 7,667 7,250
Common Stock
165 136 169 159 201 260 2,887 2,879 2,540 2,218 1,418
Retained Earnings
1,991 2,119 2,381 2,602 2,812 3,507 4,417 4,951 5,609 5,845 6,054
Accumulated Other Comprehensive Income / (Loss)
-46 -101 -47 -176 -200 -32 -163 -447 -277 -396 -222

Quarterly Balance Sheets for Revvity

This table presents Revvity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/2/2023 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 4/5/2026
Total Assets
14,219 13,422 13,565 13,433 13,425 12,770 12,392 12,361 12,363 12,139 11,997
Total Current Assets
3,523 2,913 3,001 3,059 3,159 2,448 2,350 2,318 2,236 2,144 2,128
Cash & Equivalents
1,332 1,137 913 998 1,248 1,230 1,163 1,138 992 931 860
Short-Term Investments
739 293 690 697 706 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable
627 645 633 589 597 602 632 617 661 680 691
Inventories, net
437 436 428 414 401 405 368 381 388 380 388
Other Current Assets
389 403 337 361 206 212 186 182 195 152 189
Other Current Nonoperating Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Plant, Property, & Equipment, net
491 490 510 504 503 518 482 487 499 497 466
Plant, Property & Equipment, gross
0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Accumulated Depreciation
0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Noncurrent Assets
10,204 10,019 10,054 9,869 9,763 9,803 9,561 9,556 9,628 9,498 9,403
Long-Term Investments
0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Goodwill
6,518 6,470 6,534 6,504 6,497 6,559 6,464 6,511 6,615 6,601 6,611
Intangible Assets
3,197 3,085 3,022 2,919 2,825 2,763 2,641 2,571 2,514 2,426 2,307
Other Noncurrent Operating Assets
489 463 498 446 441 482 456 473 498 472 485
Other Noncurrent Nonoperating Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
14,219 13,422 13,565 13,433 13,425 12,770 12,392 12,361 12,363 12,139 11,997
Total Liabilities
6,349 5,727 5,692 5,586 5,555 4,848 4,726 4,724 4,807 4,763 4,814
Total Current Liabilities
1,367 1,448 1,450 1,374 1,390 688 653 648 672 1,223 1,239
Short-Term Debt
479 728 722 711 711 1.05 0.24 0.24 0.23 584 576
Accounts Payable
236 188 204 184 175 176 167 178 178 176 170
Accrued Expenses
652 532 524 479 504 510 485 470 493 463 493
Other Current Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Nonoperating Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Liabilities
4,982 4,279 4,241 4,212 4,165 4,160 4,073 4,075 4,135 3,540 3,575
Long-Term Debt
3,884 3,152 3,178 3,165 3,163 3,186 3,150 3,168 3,214 2,631 2,632
Other Noncurrent Operating Liabilities
1,098 1,127 1,064 1,047 1,002 974 922 907 920 910 943
Other Noncurrent Nonoperating Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,870 7,694 7,873 7,846 7,870 7,922 7,667 7,637 7,556 7,376 7,183
Total Preferred & Common Equity
7,870 7,694 7,873 7,846 7,870 7,922 7,667 7,637 7,556 7,376 7,183
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
7,870 7,694 7,873 7,846 7,870 7,922 7,667 7,637 7,556 7,376 7,183
Common Stock
2,636 2,534 2,540 2,545 2,539 2,394 2,218 2,074 1,789 1,592 1,349
Retained Earnings
5,539 5,539 5,609 5,627 5,673 5,759 5,845 5,879 5,925 5,964 6,087
Accumulated Other Comprehensive Income / (Loss)
-305 -379 -277 -325 -342 -232 -396 -316 -157 -180 -254

Annual Metrics And Ratios for Revvity

This table displays calculated financial ratios and metrics derived from Revvity's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/3/2016 1/1/2017 12/31/2017 12/30/2018 12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.69% 0.51% 6.69% 23.08% 3.80% -7.64% 43.73% -13.48% -16.95% 0.16% 3.67%
EBITDA Growth
30.69% 8.77% 3.10% 28.75% 14.11% 78.60% 49.89% -24.08% -39.48% 5.54% -1.81%
EBIT Growth
52.07% 17.40% 0.35% 9.56% 11.76% 139.60% 45.11% -40.98% -59.53% 15.36% 2.85%
NOPAT Growth
31.48% 14.76% -39.96% 90.96% 16.47% 96.62% 36.06% -37.19% -49.52% 5.30% 2.71%
Net Income Growth
34.64% 10.30% 24.90% -18.69% -4.36% 219.87% 29.57% -39.65% 21.77% -60.99% -10.79%
EPS Growth
34.53% 13.37% 24.53% -19.32% -4.23% 218.14% 24.50% -44.31% 23.33% -60.36% -5.91%
Operating Cash Flow Growth
1.95% 22.12% -17.73% 7.83% 16.86% 145.46% 58.12% -51.81% -86.57% 588.38% -7.22%
Free Cash Flow Firm Growth
3,300.52% -15.37% -571.84% 120.91% -111.96% 264.53% -6,823.65% 120.74% -96.57% 2,901.04% -48.82%
Invested Capital Growth
-4.23% -1.29% 56.40% 0.14% 8.87% 13.33% 90.07% -2.15% 2.70% -5.07% -1.07%
Revenue Q/Q Growth
0.45% 5.81% 3.43% 4.31% 1.73% -17.64% 5.37% 10.36% 29.43% -18.79% 1.52%
EBITDA Q/Q Growth
19.77% 13.28% 1.90% 8.04% 7.06% 24.94% -1.23% -11.30% -7.38% 5.48% -1.16%
EBIT Q/Q Growth
34.73% 16.83% 0.55% 7.32% 6.65% 42.98% -9.77% -14.42% -16.71% 13.63% -1.93%
NOPAT Q/Q Growth
21.52% 11.86% -41.18% 100.70% 9.74% 36.29% -14.12% -8.70% 11.04% -0.34% 2.32%
Net Income Q/Q Growth
21.41% -1.43% -26.58% 89.56% -2.90% 76.66% -16.78% -9.90% -6.61% 6.32% 1.57%
EPS Q/Q Growth
20.65% -0.93% -26.46% 90.18% -2.86% 76.36% -19.68% -8.16% -5.45% 3.77% 4.55%
Operating Cash Flow Q/Q Growth
11.10% 7.18% -6.67% 11.20% 18.13% 42.68% -9.41% -22.42% 169.90% -60.97% 1.34%
Free Cash Flow Firm Q/Q Growth
2,125.93% 81.24% -592.22% 123.57% -149.26% -76.70% 31.75% -68.82% 111.67% 42.97% -20.47%
Invested Capital Q/Q Growth
-3.36% -6.84% 46.61% -0.28% 2.72% 10.27% -12.57% 2.68% 0.24% -2.27% -1.12%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
45.81% 47.95% 47.57% 48.27% 48.41% 64.97% 63.59% 60.08% 55.98% 55.81% 54.77%
EBITDA Margin
17.34% 18.77% 18.14% 18.97% 20.86% 40.33% 42.06% 36.91% 26.89% 28.34% 26.84%
Operating Margin
11.92% 13.92% 13.10% 11.66% 12.55% 32.56% 32.88% 22.43% 10.93% 12.59% 12.49%
EBIT Margin
11.92% 13.92% 13.10% 11.66% 12.55% 32.56% 32.88% 22.43% 10.93% 12.59% 12.49%
Profit (Net Income) Margin
10.09% 11.08% 12.97% 8.56% 7.89% 27.33% 24.64% 17.19% 25.20% 9.81% 8.45%
Tax Burden Percent
101.73% 96.00% 98.62% 92.33% 95.96% 90.98% 78.36% 87.32% 378.79% 85.53% 89.91%
Interest Burden Percent
83.21% 82.85% 100.37% 79.56% 65.51% 92.25% 95.64% 87.77% 60.88% 91.17% 75.22%
Effective Tax Rate
9.59% 11.62% 47.12% 7.84% 3.96% 21.19% 26.10% 21.35% 1.90% 10.46% 10.58%
Return on Invested Capital (ROIC)
7.95% 9.39% 4.43% 6.92% 7.71% 13.64% 12.04% 5.84% 2.94% 3.13% 3.32%
ROIC Less NNEP Spread (ROIC-NNEP)
6.09% 5.33% 15.75% 3.50% 1.07% 16.20% 12.62% 5.29% 19.48% 1.26% -0.30%
Return on Net Nonoperating Assets (RNNOA)
2.28% 1.60% 8.14% 2.43% 0.72% 8.59% 5.30% 2.00% 6.15% 0.35% -0.09%
Return on Equity (ROE)
10.23% 10.99% 12.57% 9.35% 8.43% 22.23% 17.34% 7.84% 9.09% 3.48% 3.23%
Cash Return on Invested Capital (CROIC)
12.27% 10.68% -39.57% 6.78% -0.78% 1.15% -50.06% 8.01% 0.27% 8.33% 4.40%
Operating Return on Assets (OROA)
6.05% 6.98% 5.70% 5.37% 5.79% 11.96% 10.96% 5.10% 2.17% 2.67% 2.90%
Return on Assets (ROA)
5.12% 5.55% 5.64% 3.94% 3.64% 10.04% 8.22% 3.91% 5.01% 2.08% 1.96%
Return on Common Equity (ROCE)
10.23% 10.99% 12.57% 9.35% 8.43% 22.23% 17.34% 7.84% 9.09% 3.48% 3.23%
Return on Equity Simple (ROE_SIMPLE)
10.07% 10.88% 11.69% 9.20% 8.09% 19.49% 13.21% 7.71% 8.80% 3.53% 0.00%
Net Operating Profit after Tax (NOPAT)
227 260 156 298 348 684 930 584 295 310 319
NOPAT Margin
10.78% 12.31% 6.93% 10.74% 12.06% 25.67% 24.30% 17.64% 10.72% 11.27% 11.17%
Net Nonoperating Expense Percent (NNEP)
1.86% 4.06% -11.32% 3.42% 6.64% -2.55% -0.58% 0.54% -16.54% 1.87% 3.62%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.96% 2.50% 2.87% 3.05%
Cost of Revenue to Revenue
54.19% 52.05% 52.43% 51.73% 51.59% 35.03% 36.41% 39.92% 44.02% 44.19% 45.23%
SG&A Expenses to Revenue
27.90% 27.91% 27.74% 29.23% 28.27% 26.90% 25.48% 30.97% 37.18% 36.08% 34.73%
R&D to Revenue
5.35% 5.87% 6.18% 6.98% 6.57% 5.50% 5.23% 6.69% 7.87% 7.14% 7.56%
Operating Expenses to Revenue
33.89% 34.02% 34.48% 36.61% 35.86% 32.69% 30.71% 37.66% 45.05% 43.23% 42.29%
Earnings before Interest and Taxes (EBIT)
251 295 296 324 362 867 1,258 743 301 347 357
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
365 397 409 527 601 1,074 1,610 1,222 740 781 767
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.76 2.59 3.16 3.28 3.79 4.26 3.53 2.39 1.71 1.78 1.51
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.77 2.64 3.51 3.05 3.70 5.98 6.58 5.32 4.89 4.94 3.84
Price to Earnings (P/E)
27.45 23.84 27.05 35.61 46.85 21.89 26.72 30.95 19.40 50.38 45.45
Dividend Yield
0.54% 0.55% 0.39% 0.37% 0.29% 0.20% 0.14% 0.20% 0.26% 0.25% 0.29%
Earnings Yield
3.64% 4.20% 3.70% 2.81% 2.13% 4.57% 3.74% 3.23% 5.15% 1.99% 2.20%
Enterprise Value to Invested Capital (EV/IC)
2.37 2.28 2.26 2.36 2.67 3.29 2.92 2.18 1.55 1.62 1.39
Enterprise Value to Revenue (EV/Rev)
3.14 2.96 4.31 3.67 4.35 6.58 7.73 6.51 5.72 5.67 4.64
Enterprise Value to EBITDA (EV/EBITDA)
18.09 15.80 23.74 19.36 20.85 16.31 18.37 17.64 21.28 19.99 17.30
Enterprise Value to EBIT (EV/EBIT)
26.32 21.29 32.88 31.50 34.65 20.20 23.51 29.02 52.38 45.02 37.19
Enterprise Value to NOPAT (EV/NOPAT)
29.12 24.09 62.18 34.18 36.08 25.63 31.81 36.90 53.39 50.27 41.59
Enterprise Value to Operating Cash Flow (EV/OCF)
23.01 17.89 33.70 32.80 34.51 19.64 20.97 31.71 172.49 24.84 22.75
Enterprise Value to Free Cash Flow (EV/FCFF)
18.87 21.17 0.00 34.91 0.00 304.73 0.00 26.88 572.28 18.91 31.39
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.48 0.49 0.80 0.73 0.74 0.53 0.70 0.60 0.50 0.41 0.44
Long-Term Debt to Equity
0.48 0.49 0.71 0.73 0.73 0.43 0.70 0.53 0.40 0.41 0.36
Financial Leverage
0.37 0.30 0.52 0.70 0.67 0.53 0.42 0.38 0.32 0.28 0.29
Leverage Ratio
2.00 1.98 2.23 2.37 2.32 2.21 2.11 2.01 1.82 1.67 1.65
Compound Leverage Factor
1.66 1.64 2.23 1.89 1.52 2.04 2.02 1.76 1.11 1.52 1.24
Debt to Total Capital
32.43% 32.70% 44.49% 42.25% 42.43% 34.76% 41.10% 37.31% 33.13% 29.13% 30.75%
Short-Term Debt to Total Capital
0.04% 0.04% 4.82% 0.33% 0.20% 6.65% 0.04% 4.00% 6.13% 0.00% 5.62%
Long-Term Debt to Total Capital
32.39% 32.66% 39.67% 41.92% 42.23% 28.11% 41.07% 33.31% 26.99% 29.12% 25.13%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
67.57% 67.30% 55.51% 57.75% 57.57% 65.24% 58.90% 62.69% 66.87% 70.87% 69.25%
Debt to EBITDA
2.77 2.64 4.90 3.59 3.45 1.85 3.10 3.60 5.27 4.04 4.20
Net Debt to EBITDA
2.12 1.73 4.41 3.28 3.13 1.48 2.72 3.22 3.10 2.55 3.00
Long-Term Debt to EBITDA
2.77 2.63 4.37 3.56 3.43 1.50 3.09 3.21 4.30 4.04 3.43
Debt to NOPAT
4.46 4.02 12.83 6.34 5.97 2.91 5.36 7.52 13.23 10.15 10.10
Net Debt to NOPAT
3.42 2.64 11.54 5.79 5.41 2.32 4.71 6.74 7.79 6.40 7.21
Long-Term Debt to NOPAT
4.46 4.01 11.44 6.29 5.94 2.36 5.35 6.72 10.78 10.15 8.25
Altman Z-Score
3.21 3.16 2.45 2.85 3.06 3.66 2.97 2.61 2.41 2.87 2.46
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.84 1.97 1.26 1.60 1.80 1.36 2.01 2.13 2.07 3.60 1.68
Quick Ratio
1.16 1.30 0.79 1.03 1.20 0.94 1.08 0.69 1.54 2.75 1.25
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
350 296 -1,398 292 -35 57 -3,866 802 28 826 423
Operating Cash Flow to CapEx
1,017.43% 1,105.97% 737.94% 333.54% 476.17% 1,402.04% 1,640.03% 793.87% 112.17% 725.12% 792.87%
Free Cash Flow to Firm to Interest Expense
8.31 5.86 0.00 4.41 -0.28 0.86 -70.44 8.82 0.23 26.97 4.78
Operating Cash Flow to Interest Expense
6.82 6.94 0.00 4.70 2.91 13.28 25.71 7.48 0.78 20.52 6.60
Operating Cash Flow Less CapEx to Interest Expense
6.15 6.31 0.00 3.29 2.30 12.33 24.14 6.54 0.08 17.69 5.77
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.51 0.50 0.44 0.46 0.46 0.37 0.33 0.23 0.20 0.21 0.23
Accounts Receivable Turnover
4.75 5.03 4.62 4.69 4.25 2.83 4.11 5.02 4.42 4.36 4.15
Inventory Turnover
4.19 4.35 3.95 4.17 4.28 2.14 2.96 3.18 2.91 3.06 3.46
Fixed Asset Turnover
13.42 14.95 10.18 9.01 9.06 7.76 8.97 6.84 5.54 5.56 5.94
Accounts Payable Turnover
7.24 7.13 6.07 6.49 6.51 3.31 4.27 4.42 5.08 6.55 7.32
Days Sales Outstanding (DSO)
76.79 72.52 79.07 77.85 85.93 128.85 88.83 72.78 82.64 83.81 87.99
Days Inventory Outstanding (DIO)
87.19 83.92 92.32 87.63 85.30 170.46 123.14 114.77 125.63 119.28 105.55
Days Payable Outstanding (DPO)
50.39 51.21 60.17 56.26 56.04 110.16 85.39 82.50 71.88 55.71 49.86
Cash Conversion Cycle (CCC)
113.59 105.22 111.22 109.21 115.19 189.16 126.58 105.04 136.39 147.38 143.68
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,791 2,755 4,309 4,315 4,698 5,324 10,120 9,902 10,169 9,654 9,551
Invested Capital Turnover
0.74 0.76 0.64 0.64 0.64 0.53 0.50 0.33 0.27 0.28 0.30
Increase / (Decrease) in Invested Capital
-123 -36 1,554 6.22 383 626 4,796 -218 267 -515 -104
Enterprise Value (EV)
6,606 6,272 9,719 10,202 12,542 17,520 29,584 21,556 15,744 15,609 13,263
Market Capitalization
5,831 5,585 7,915 8,474 10,660 15,931 25,203 17,616 13,447 13,621 10,962
Book Value per Share
$18.85 $19.66 $22.71 $23.24 $25.33 $33.36 $56.59 $58.45 $63.79 $63.00 $63.95
Tangible Book Value per Share
($5.47) ($4.70) ($16.75) ($14.09) ($14.23) ($9.62) ($26.21) ($19.60) ($13.64) ($11.81) ($15.08)
Total Capital
3,123 3,200 4,509 4,476 4,888 5,726 12,125 11,777 11,772 10,818 10,470
Total Debt
1,013 1,046 2,006 1,891 2,074 1,991 4,984 4,394 3,900 3,151 3,220
Total Long-Term Debt
1,012 1,045 1,789 1,877 2,064 1,610 4,980 3,923 3,178 3,150 2,631
Net Debt
775 687 1,804 1,728 1,882 1,589 4,381 3,940 2,297 1,987 2,300
Capital Expenditures (CapEx)
28 32 39 93 76 64 86 86 81 87 74
Debt-free, Cash-free Net Working Capital (DFCFNWC)
235 228 264 315 430 566 628 1,761 669 533 577
Debt-free Net Working Capital (DFNWC)
473 588 466 478 622 968 1,231 2,215 2,273 1,697 1,497
Net Working Capital (NWC)
472 587 249 463 612 587 1,227 1,744 1,551 1,697 909
Net Nonoperating Expense (NNE)
14 26 -136 61 120 -44 -13 15 -398 40 78
Net Nonoperating Obligations (NNO)
681 602 1,806 1,731 1,884 1,589 2,978 2,519 2,297 1,987 2,300
Total Depreciation and Amortization (D&A)
114 103 114 203 239 207 352 480 439 434 410
Debt-free, Cash-free Net Working Capital to Revenue
11.16% 10.80% 11.71% 11.33% 14.90% 21.24% 16.41% 53.16% 24.34% 19.36% 20.22%
Debt-free Net Working Capital to Revenue
22.46% 27.78% 20.66% 17.20% 21.55% 36.33% 32.17% 66.88% 82.62% 61.59% 52.43%
Net Working Capital to Revenue
22.41% 27.73% 11.03% 16.67% 21.21% 22.03% 32.06% 52.66% 56.37% 61.58% 31.81%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.89 $2.14 $2.67 $2.15 $2.06 $6.53 $8.12 $4.51 $5.56 $2.21 $2.07
Adjusted Weighted Average Basic Shares Outstanding
109.79M 109.79M 110.50M 110.80M 111.30M 112.06M 126.18M 126.41M 123.53M 120.19M 111.80M
Adjusted Diluted Earnings per Share
$1.87 $2.12 $2.64 $2.13 $2.04 $6.49 $8.08 $4.50 $5.55 $2.20 $2.07
Adjusted Weighted Average Diluted Shares Outstanding
109.79M 109.79M 110.50M 110.80M 111.30M 112.06M 126.18M 126.41M 123.53M 120.19M 111.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
109.79M 109.79M 110.50M 110.80M 111.30M 112.06M 126.18M 126.41M 123.53M 120.19M 111.80M
Normalized Net Operating Profit after Tax (NOPAT)
239 265 163 309 376 690 930 584 295 310 319
Normalized NOPAT Margin
11.36% 12.52% 7.22% 11.11% 13.04% 25.89% 24.30% 17.64% 10.72% 11.27% 11.17%
Pre Tax Income Margin
9.92% 11.54% 13.15% 9.28% 8.22% 30.04% 31.44% 19.68% 6.65% 11.47% 9.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.96 5.83 0.00 4.89 2.90 12.91 22.93 8.17 2.56 11.33 4.04
NOPAT to Interest Expense
5.39 5.15 0.00 4.51 2.78 10.17 16.95 6.43 2.51 10.14 3.61
EBIT Less CapEx to Interest Expense
5.29 5.20 0.00 3.48 2.29 11.96 21.37 7.23 1.86 8.50 3.20
NOPAT Less CapEx to Interest Expense
4.72 4.53 0.00 3.10 2.17 9.22 15.38 5.49 1.82 7.31 2.78
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
14.86% 13.15% 10.52% 13.03% 13.65% 4.29% 3.43% 6.21% 5.04% 12.74% 13.60%
Augmented Payout Ratio
50.85% 77.93% 11.83% 37.18% 16.42% 5.24% 11.18% 20.38% 61.15% 149.43% 353.90%

Quarterly Metrics And Ratios for Revvity

This table displays calculated financial ratios and metrics derived from Revvity's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/1/2023 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 4/5/2026
DEI Shares Outstanding
- - - - - - - - - - 111,799,374.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 111,799,374.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.36
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-100.00% 84.38% -3.70% -2.45% 0.00% -46.63% 2.28% 4.13% 2.18% 5.85% 6.97%
EBITDA Growth
-21.64% -24.23% -17.80% 3.08% 15.54% 21.99% 11.13% -0.04% -10.69% -4.00% 6.63%
EBIT Growth
-37.51% -43.87% -42.04% 9.82% 41.78% 53.90% 63.73% 5.87% -16.56% -5.90% 5.06%
NOPAT Growth
-52.61% 61.46% -42.96% 12.31% 105.61% -28.99% 56.81% 1.65% -23.96% 5.31% 8.03%
Net Income Growth
-88.87% -38.46% -95.43% 55.68% 893.65% 20.47% 62.37% -2.55% -50.56% 3.93% -3.60%
EPS Growth
-88.06% -31.68% -95.33% 60.71% 862.50% 11.59% 66.67% 2.22% -48.05% 11.69% 2.86%
Operating Cash Flow Growth
-120.93% 41.29% 132.52% 217.22% 541.65% -11.38% -13.15% -15.32% -6.35% 4.44% -10.09%
Free Cash Flow Firm Growth
-122.56% -135.31% -103.81% -62.96% 178.20% 663.85% 821.04% -80.99% -19.08% -64.78% -52.05%
Invested Capital Growth
5.20% 2.70% 0.95% -3.66% -2.62% -5.07% -3.58% -0.12% -2.22% -1.07% -1.43%
Revenue Q/Q Growth
-100.00% 0.00% -52.44% 6.43% -1.10% 6.63% -8.86% 8.35% -2.96% 10.46% -7.89%
EBITDA Q/Q Growth
-5.05% 2.68% -16.62% 26.81% 6.43% 8.41% -24.04% 14.06% -4.91% 16.54% -15.63%
EBIT Q/Q Growth
-11.31% 11.46% -42.82% 94.32% 14.50% 20.99% -39.17% 25.65% -9.77% 36.45% -32.09%
NOPAT Q/Q Growth
-30.54% 251.89% -76.56% 96.00% 27.17% 21.53% -48.23% 27.06% -4.88% 68.31% -46.89%
Net Income Q/Q Growth
-73.29% 727.24% -66.89% 112.82% 70.46% 0.29% -55.37% 27.73% -13.52% 110.85% -58.60%
EPS Q/Q Growth
-71.43% 762.50% -69.57% 114.29% 71.11% 0.00% -54.55% 31.43% -13.04% 115.00% -58.14%
Operating Cash Flow Q/Q Growth
75.25% 687.17% -87.23% 7.49% -6.77% 17.81% -26.44% 4.81% 3.11% 31.38% -36.67%
Free Cash Flow Firm Q/Q Growth
-138.16% 75.69% 47.94% 866.90% -19.42% 75.26% -33.42% -79.78% 243.02% -23.71% -9.36%
Invested Capital Q/Q Growth
-0.17% 0.24% -1.39% -2.37% 0.90% -2.27% 0.14% 1.15% -1.23% -1.12% -0.21%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 77.14% 54.63% 55.73% 56.26% 56.53% 56.49% 54.50% 53.60% 54.62% 54.51%
EBITDA Margin
0.00% 13.48% 23.64% 28.17% 30.31% 30.82% 25.69% 27.04% 26.50% 27.95% 25.60%
Operating Margin
0.00% 5.65% 6.79% 12.39% 14.35% 16.28% 10.87% 12.60% 11.72% 14.47% 10.67%
EBIT Margin
0.00% 5.65% 6.79% 12.39% 14.35% 16.28% 10.87% 12.60% 11.72% 14.47% 10.67%
Profit (Net Income) Margin
0.00% 5.75% 4.00% 8.00% 13.80% 12.98% 6.35% 7.49% 6.67% 12.74% 5.73%
Tax Burden Percent
18.77% 250.37% 75.29% 63.88% 94.03% 100.09% 80.63% 78.58% 83.78% 107.43% 81.45%
Interest Burden Percent
73.10% 40.67% 78.31% 101.09% 102.25% 79.63% 72.52% 75.64% 67.99% 81.93% 65.88%
Effective Tax Rate
35.84% -102.58% 16.94% 16.22% 6.95% 6.53% 20.45% 19.56% 15.20% -4.60% 18.20%
Return on Invested Capital (ROIC)
0.00% 3.13% 1.54% 2.82% 4.52% 4.23% 2.43% 2.90% 2.86% 4.50% 2.64%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -0.09% 1.02% 2.04% 4.66% 3.47% 1.71% 1.98% 1.79% 3.64% 1.66%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.03% 0.26% 0.55% 1.32% 0.96% 0.46% 0.53% 0.50% 1.05% 0.49%
Return on Equity (ROE)
0.00% 3.11% 1.80% 3.36% 5.84% 5.19% 2.90% 3.43% 3.36% 5.55% 3.13%
Cash Return on Invested Capital (CROIC)
-2.38% 0.27% 1.68% 6.41% 5.77% 8.33% 7.02% 3.54% 5.44% 4.40% 4.81%
Operating Return on Assets (OROA)
0.00% 1.12% 1.32% 2.43% 3.72% 3.46% 2.33% 2.73% 2.65% 3.37% 2.54%
Return on Assets (ROA)
0.00% 1.14% 0.78% 1.57% 3.57% 2.75% 1.36% 1.63% 1.51% 2.96% 1.36%
Return on Common Equity (ROCE)
0.00% 3.11% 1.80% 3.36% 5.84% 5.19% 2.90% 3.43% 3.36% 5.55% 3.13%
Return on Equity Simple (ROE_SIMPLE)
9.65% 0.00% 1.91% 2.15% 3.21% 0.00% 3.75% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
44 156 37 72 91 111 57 73 69 117 62
NOPAT Margin
0.00% 11.44% 5.64% 10.38% 13.35% 15.22% 8.64% 10.14% 9.94% 15.14% 8.73%
Net Nonoperating Expense Percent (NNEP)
1.39% 3.23% 0.52% 0.78% -0.14% 0.76% 0.72% 0.92% 1.08% 0.86% 0.98%
Return On Investment Capital (ROIC_SIMPLE)
- 1.33% - - - 1.03% 0.53% 0.68% 0.66% 1.12% 0.60%
Cost of Revenue to Revenue
0.00% 22.86% 45.37% 44.27% 43.74% 43.47% 43.51% 45.50% 46.40% 45.38% 45.49%
SG&A Expenses to Revenue
0.00% 18.79% 40.09% 36.38% 34.72% 33.50% 37.57% 34.50% 34.61% 32.61% 35.70%
R&D to Revenue
0.00% 3.63% 7.75% 6.96% 7.18% 6.75% 8.06% 7.40% 7.27% 7.54% 8.14%
Operating Expenses to Revenue
0.00% 71.49% 47.84% 43.34% 41.91% 40.25% 45.63% 41.90% 41.88% 40.14% 43.84%
Earnings before Interest and Taxes (EBIT)
69 77 44 86 98 119 72 91 82 112 76
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
179 184 154 195 207 225 171 195 185 216 182
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.78 1.71 1.65 1.64 1.96 1.78 1.66 1.52 1.32 1.51 1.38
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.45 4.89 4.74 4.77 4.58 4.94 4.58 4.12 3.47 3.84 3.42
Price to Earnings (P/E)
18.45 19.40 86.43 76.27 61.10 50.38 44.26 40.40 41.05 45.45 41.45
Dividend Yield
0.25% 0.26% 0.27% 0.27% 0.22% 0.25% 0.27% 0.29% 0.33% 0.29% 0.32%
Earnings Yield
5.42% 5.15% 1.16% 1.31% 1.64% 1.99% 2.26% 2.48% 2.44% 2.20% 2.41%
Enterprise Value to Invested Capital (EV/IC)
1.59 1.55 1.51 1.52 1.77 1.62 1.52 1.41 1.25 1.39 1.29
Enterprise Value to Revenue (EV/Rev)
7.60 5.72 5.55 5.48 5.16 5.67 5.31 4.91 4.28 4.64 4.23
Enterprise Value to EBITDA (EV/EBITDA)
20.22 21.28 21.40 20.84 23.64 19.99 18.45 17.23 15.52 17.30 15.79
Enterprise Value to EBIT (EV/EBIT)
44.74 52.38 56.28 53.73 57.33 45.02 39.26 36.18 33.09 37.19 34.09
Enterprise Value to NOPAT (EV/NOPAT)
60.81 53.39 57.73 55.33 56.16 50.27 44.28 41.02 38.61 41.59 37.91
Enterprise Value to Operating Cash Flow (EV/OCF)
477.48 172.49 13.32 10.39 10.87 24.84 24.17 23.51 20.92 22.75 21.55
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 572.28 90.31 23.20 30.30 18.91 21.28 39.69 22.65 31.39 26.60
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.50 0.50 0.49 0.49 0.40 0.41 0.41 0.43 0.44 0.44 0.45
Long-Term Debt to Equity
0.41 0.40 0.40 0.40 0.40 0.41 0.41 0.43 0.36 0.36 0.37
Financial Leverage
0.34 0.32 0.26 0.27 0.28 0.28 0.27 0.27 0.28 0.29 0.30
Leverage Ratio
1.85 1.82 1.77 1.76 1.68 1.67 1.67 1.67 1.63 1.65 1.64
Compound Leverage Factor
1.35 0.74 1.38 1.78 1.71 1.33 1.21 1.26 1.11 1.35 1.08
Debt to Total Capital
33.52% 33.13% 33.07% 32.99% 28.69% 29.13% 29.32% 29.85% 30.35% 30.75% 30.87%
Short-Term Debt to Total Capital
6.29% 6.13% 6.07% 6.06% 0.01% 0.00% 0.00% 0.00% 5.51% 5.62% 5.54%
Long-Term Debt to Total Capital
27.24% 26.99% 27.00% 26.93% 28.68% 29.12% 29.32% 29.84% 24.84% 25.13% 25.33%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.48% 66.87% 66.93% 67.01% 71.31% 70.87% 70.68% 70.15% 69.65% 69.25% 69.13%
Debt to EBITDA
4.86 5.27 5.49 5.44 4.31 4.04 3.97 4.03 4.15 4.20 4.12
Net Debt to EBITDA
3.07 3.10 3.09 2.70 2.64 2.55 2.55 2.79 2.94 3.00 3.02
Long-Term Debt to EBITDA
3.95 4.30 4.48 4.44 4.30 4.04 3.97 4.03 3.39 3.43 3.38
Debt to NOPAT
14.61 13.23 14.81 14.44 10.23 10.15 9.54 9.59 10.31 10.10 9.90
Net Debt to NOPAT
9.23 7.79 8.33 7.16 6.28 6.40 6.11 6.63 7.33 7.21 7.25
Long-Term Debt to NOPAT
11.87 10.78 12.09 11.79 10.23 10.15 9.53 9.59 8.44 8.25 8.12
Altman Z-Score
2.32 2.36 2.34 2.37 3.01 2.81 2.68 2.51 2.26 2.39 2.30
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.01 2.07 2.23 2.27 3.56 3.60 3.58 3.33 1.75 1.68 1.72
Quick Ratio
1.43 1.54 1.66 1.84 2.66 2.75 2.71 2.46 1.32 1.25 1.25
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-457 -111 -58 443 357 626 417 84 289 221 200
Operating Cash Flow to CapEx
-149.77% 815.28% 826.96% 719.99% 662.60% 712.48% 801.87% 711.88% 748.61% 902.09% 1,069.72%
Free Cash Flow to Firm to Interest Expense
-24.53 -2.43 -6.04 0.00 0.00 25.88 21.00 3.81 11.03 10.92 7.72
Operating Cash Flow to Interest Expense
-1.80 4.29 15.42 0.00 0.00 7.20 6.46 6.08 5.28 9.01 4.45
Operating Cash Flow Less CapEx to Interest Expense
-3.00 3.77 13.56 0.00 0.00 6.19 5.65 5.22 4.58 8.01 4.03
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.16 0.20 0.19 0.20 0.26 0.21 0.21 0.22 0.23 0.23 0.24
Accounts Receivable Turnover
3.59 4.42 4.64 4.42 5.44 4.36 4.59 4.45 4.39 4.15 4.44
Inventory Turnover
2.96 2.91 2.87 2.89 2.89 3.06 3.05 3.12 3.21 3.46 3.45
Fixed Asset Turnover
4.47 5.54 5.48 5.45 6.73 5.56 5.59 5.59 5.54 5.94 6.10
Accounts Payable Turnover
5.19 5.08 5.38 5.90 6.65 6.55 6.70 6.99 7.15 7.32 7.63
Days Sales Outstanding (DSO)
101.80 82.64 78.73 82.51 67.07 83.81 79.49 82.08 83.19 87.99 82.30
Days Inventory Outstanding (DIO)
123.44 125.63 126.98 126.25 126.45 119.28 119.79 116.89 113.77 105.55 105.82
Days Payable Outstanding (DPO)
70.39 71.88 67.81 61.84 54.88 55.71 54.46 52.24 51.08 49.86 47.87
Cash Conversion Cycle (CCC)
154.86 136.39 137.90 146.92 138.64 147.38 144.81 146.73 145.88 143.68 140.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,145 10,169 10,028 9,790 9,879 9,654 9,668 9,779 9,659 9,551 9,530
Invested Capital Turnover
0.21 0.27 0.27 0.27 0.34 0.28 0.28 0.29 0.29 0.30 0.30
Increase / (Decrease) in Invested Capital
501 267 94 -372 -266 -515 -359 -11 -220 -104 -138
Enterprise Value (EV)
16,147 15,744 15,114 14,843 17,496 15,609 14,716 13,744 12,033 13,263 12,283
Market Capitalization
13,697 13,447 12,933 12,923 15,539 13,621 12,685 11,522 9,750 10,962 9,936
Book Value per Share
$61.98 $63.79 $63.57 $63.78 $64.23 $63.00 $63.54 $64.11 $63.55 $63.95 $64.25
Tangible Book Value per Share
($14.99) ($13.64) ($12.77) ($11.77) ($11.35) ($11.81) ($12.03) ($13.35) ($14.22) ($15.08) ($15.51)
Total Capital
11,574 11,772 11,723 11,744 11,108 10,818 10,806 10,771 10,590 10,470 10,391
Total Debt
3,880 3,900 3,876 3,874 3,187 3,151 3,169 3,215 3,215 3,220 3,208
Total Long-Term Debt
3,152 3,178 3,165 3,163 3,186 3,150 3,168 3,214 2,631 2,631 2,632
Net Debt
2,450 2,297 2,181 1,920 1,957 1,987 2,031 2,223 2,283 2,300 2,348
Capital Expenditures (CapEx)
22 24 18 22 22 24 16 19 19 20 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
763 669 701 526 532 533 532 573 574 577 605
Debt-free Net Working Capital (DFNWC)
2,193 2,273 2,397 2,480 1,762 1,697 1,670 1,565 1,505 1,497 1,466
Net Working Capital (NWC)
1,465 1,551 1,685 1,769 1,760 1,697 1,670 1,564 921 909 890
Net Nonoperating Expense (NNE)
35 78 11 16 -3.03 16 15 19 23 19 21
Net Nonoperating Obligations (NNO)
2,450 2,297 2,181 1,920 1,957 1,987 2,031 2,223 2,283 2,300 2,348
Total Depreciation and Amortization (D&A)
110 107 110 109 109 106 99 104 103 104 106
Debt-free, Cash-free Net Working Capital to Revenue
35.91% 24.34% 25.72% 19.42% 15.67% 19.36% 19.22% 20.47% 20.38% 20.22% 20.85%
Debt-free Net Working Capital to Revenue
103.19% 82.62% 87.93% 91.58% 51.93% 61.59% 60.29% 55.91% 53.49% 52.43% 50.49%
Net Working Capital to Revenue
68.95% 56.37% 61.83% 65.31% 51.90% 61.58% 60.28% 55.90% 32.74% 31.81% 30.65%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.08 $0.69 $0.21 $0.45 $0.77 $0.78 $0.35 $0.46 $0.40 $0.86 $0.36
Adjusted Weighted Average Basic Shares Outstanding
123.99M 123.53M 123.43M 123.35M 122.81M 120.19M 120.14M 117.51M 115.41M 111.80M 111.85M
Adjusted Diluted Earnings per Share
$0.08 $0.69 $0.21 $0.45 $0.77 $0.77 $0.35 $0.46 $0.40 $0.86 $0.36
Adjusted Weighted Average Diluted Shares Outstanding
124.20M 123.53M 123.54M 123.48M 123.03M 120.19M 120.23M 117.54M 115.46M 111.80M 111.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
123.41M 123.53M 123.39M 123.34M 121.70M 120.19M 117.87M 116.07M 113.38M 111.80M 111.56M
Normalized Net Operating Profit after Tax (NOPAT)
44 54 37 72 91 111 57 73 69 78 62
Normalized NOPAT Margin
0.00% 3.95% 5.64% 10.38% 13.35% 15.22% 8.64% 10.14% 9.94% 10.13% 8.73%
Pre Tax Income Margin
0.00% 2.30% 5.32% 12.53% 14.67% 12.96% 7.88% 9.53% 7.97% 11.86% 7.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.72 1.69 4.61 0.00 0.00 4.91 3.64 4.10 3.12 5.54 2.93
NOPAT to Interest Expense
2.38 3.41 3.83 0.00 0.00 4.59 2.89 3.30 2.65 5.79 2.40
EBIT Less CapEx to Interest Expense
2.52 1.16 2.75 0.00 0.00 3.90 2.83 3.25 2.42 4.54 2.51
NOPAT Less CapEx to Interest Expense
1.18 2.89 1.96 0.00 0.00 3.58 2.09 2.45 1.94 4.79 1.98
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
4.74% 5.04% 23.23% 20.43% 13.59% 12.74% 11.95% 11.88% 14.06% 13.60% 13.44%
Augmented Payout Ratio
59.78% 61.15% 249.11% 106.53% 88.02% 149.43% 190.73% 287.75% 366.79% 353.90% 327.90%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, investor‑focused trend snapshot for Revvity, Inc. (NYSE: RVTY) using the last four years of quarterly statements provided (through Q4 2025). The focus is on what the data suggests about the company’s profitability, cash flow, and liquidity trends over time.

  • Operating cash flow has remained strong and positive in every 2025 quarter, with Net Cash From Continuing Operating Activities around 134–182 million per quarter (Q4 2025: about 181.96 million), supporting ongoing liquidity and potential for free cash flow generation.
  • Gross margins have stayed in the mid‑50% range across 2025 quarters (Q4 2025 approx. 54.6%, Q3 2025 approx. 53.6%, Q2 2025 approx. 54.5%, Q1 2025 approx. 56.5%), indicating stable core profitability from operations.
  • Net income attributable to common shareholders rose notably in Q4 2025 to about 98.36 million, marking a clear quarterly uplift in profitability.
  • The company has pursued substantive capital returns to shareholders via share repurchases in 2025 (examples: roughly 168–205 million per quarter), which can be viewed positively by investors seeking returns on equity.
  • The balance sheet shows a robust equity base (Total Equity generally in the 7.3–7.8 billion range in 2025) and a solid cash position (cash and equivalents often near or above 0.9–1.0 billion), providing financial flexibility.
  • Revenue displays quarterly volatility rather than a simple, consistent uptrend, with quarterly operating revenue in the 0.66–0.77 billion range in 2025.
  • The balance sheet includes substantial goodwill and intangible assets (Goodwill often several billions; intangible assets also in the billions), which could pose impairment risk if market conditions deteriorate.
  • Debt levels are meaningful (long‑term debt in the low‑to‑mid billions; total liabilities several billions), representing ongoing leverage that could press cash flows if interest rates rise or if revenue momentum weakens.
  • Financing activities are a recurring cash outflow, dominated by large share repurchases and other financing outflows (for example, net cash from financing activities shows notable negative values in several quarters, including around −176 million in Q4 2025 and substantial reductions in continuing financing activities), which reduces cash reserves unless offset by operating cash and investing flows.
  • While 2025 CFO is positive, the combined effect of ongoing financing outflows and debt servicing could pressure liquidity if operating cash flow weakens or capex/R&D funding intensifies in the future.
05/21/26 06:43 PM ETAI Generated. May Contain Errors.

Revvity Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Revvity's fiscal year ends in December. Their fiscal year 2025 ended on December 28, 2025.

Revvity's net income appears to be on an upward trend, with a most recent value of $241.20 million in 2025, rising from $212.43 million in 2015. The previous period was $270.39 million in 2024. Check out Revvity's forecast to explore projected trends and price targets.

Revvity's total operating income in 2025 was $356.64 million, based on the following breakdown:
  • Total Gross Profit: $1.56 billion
  • Total Operating Expenses: $1.21 billion

Over the last 10 years, Revvity's total revenue changed from $2.10 billion in 2015 to $2.86 billion in 2025, a change of 35.7%.

Revvity's total liabilities were at $4.92 billion at the end of 2025, a 4.1% increase from 2024, and a 139.2% increase since 2015.

In the past 10 years, Revvity's cash and equivalents has ranged from $163.11 million in 2018 to $1.16 billion in 2024, and is currently $919.86 million as of their latest financial filing in 2025.

Over the last 10 years, Revvity's book value per share changed from 18.85 in 2015 to 63.95 in 2025, a change of 239.2%.



Financial statements for NYSE:RVTY last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners